Skip to main content
main-content

Connective tissue diseases

Myositis

14-12-2018 | Pediatric | Article

Off-label use of tocilizumab to treat non-juvenile idiopathic arthritis in pediatric rheumatic patients: a literature review

Jung JY et al. Pediatr Rheumatol 2018; 16: 79. doi: 10.1186/s12969-018-0296-z

20-11-2018 | Myositis | Article

Long-term follow-up of autologous hematopoietic stem cell transplantation for refractory juvenile dermatomyositis: A case-series study

Zhu J et al. Pediatr Rheumatol 2018; 16: 72. doi: 10.1186/s12969-018-0284-3

Rheumatic immune-related adverse events from cancer immunotherapy

In this review, mechanisms of action of checkpoint inhibitors and how they might cause rheumatic immune-related adverse events are described [read more].
Calabrese LH, Calabrese C, Cappelli LC. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0074-9

15-09-2018 | Myositis | Review | Article

Current treatment for myositis

Barsotti S, Lundberg IE. Curr Treat Options in Rheum 2018. doi: 10.1007/s40674-018-0106-2

31-08-2018 | Immune checkpoint inhibitor-induced rheumatic disease | Review | Article

Rheumatic immune-related adverse events from cancer immunotherapy

Calabrese LH, Calabrese C, Cappelli LC. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0074-9

03-08-2018 | Pathophysiology | Review | Article

S100 proteins in rheumatic diseases

Austermann J, Spiekermann C, Roth J. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0058-9

16-07-2018 | Dermatomyositis | Article

Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis

Mamyrova G et al. Rheumatology (Oxford) 2018. doi: 10.1093/rheumatology/key190

11-07-2018 | Pediatric | Review | Article

Pediatric Rheumatology Collaborative Study Group: Over four decades of pivotal clinical drug research in pediatric rheumatology

Brunner HI et al. Pediatr Rheumatol 2018; 16: 45. doi: 10.1186/s12969-018-0261-x

03-07-2018 | Vasculitis | Article

Oral cyclophosphamide in treatment of patients with refractory idiopathic inflammatory myopathies: A retrospective observational study

Bae S, Charles-Schoeman C. Clin Rheumatol 2018; 37: 2113–2123. doi: 10.1007/s10067-018-4174-3

28-06-2018 | Myositis | Review | Article

Update on inclusion body myositis

Jabari D et al. Curr Rheumatol Rep 2018; 20: 52. doi: 10.1007/s11926-018-0755-z

12-06-2018 | Dermatomyositis | Article

Introduction of a novel magnetic resonance imaging-based scoring system for assessing disease activity in children with juvenile dermatomyositis

Thyoka M et al. Rheumatology (Oxford) 2018: key144. doi: 10.1093/rheumatology/key144

26-05-2018 | Systemic sclerosis | Article

Vascular complications in systemic sclerosis: A prospective cohort study

Mecoli CA et al. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4148-5

20-04-2018 | Myositis | Review | Article

Autoantibodies in myositis

McHugh NJ, Tansley SL. Nat Rev Rheumatol 2018; 14: 290–302. doi: 10.1038/nrrheum.2018.56

20-04-2018 | Myositis | Review | Article

Risk factors and disease mechanisms in myositis

Miller FW et al. Nat Rev Rheumatol 2018; 14: 255–268. doi: 10.1038/nrrheum.2018.48

12-04-2018 | Myositis | Review | Article

Classification of myositis

Lundberg IE, de Visser M, Werth VP. Nat Rev Rheumatol 2018; 14: 269–278. doi: 10.1038/nrrheum.2018.41

12-04-2018 | Myositis | Review | Article

Update on outcome assessment in myositis

Rider LG et al. Nat Rev Rheumatol 2018; 14: 303–318. doi: 10.1038/nrrheum.2018.33

29-03-2018 | Myositis | Review | Article

Treatment in myositis

Oddis CV, Aggarwal R. Nat Rev Rheumatol 2018; 14: 279–289. doi: 10.1038/nrrheum.2018.42

image credits